Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study

@article{DeVito2020ComplianceWL,
  title={Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study},
  author={N. DeVito and S. Bacon and B. Goldacre},
  journal={The Lancet},
  year={2020},
  volume={395},
  pages={361-369}
}
  • N. DeVito, S. Bacon, B. Goldacre
  • Published 2020
  • Medicine
  • The Lancet
  • BACKGROUND Failure to report the results of a clinical trial can distort the evidence base for clinical practice, breaches researchers' ethical obligations to participants, and represents an important source of research waste. The Food and Drug Administration Amendments Act (FDAAA) of 2007 now requires sponsors of applicable trials to report their results directly onto ClinicalTrials.gov within 1 year of completion. The first trials covered by the Final Rule of this act became due to report… CONTINUE READING
    32 Citations
    Study design, result posting and publication of late-stage cardiovascular trials.
    P-hacking in clinical trials and how incentives shape the distribution of results across phases
    • PDF
    The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020
    Limitations of Randomized Clinical Trials.
    Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics
    • PDF

    References

    SHOWING 1-10 OF 25 REFERENCES
    Compliance with results reporting at ClinicalTrials.gov.
    • 140
    • PDF